J&J/Centocor Seek To Expand Remicade Psoriatic Arthritis Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
sBLA for the arthritis medication seeks to add inhibition of disease progression to labeling.
You may also be interested in...
J&J/Centocor’s Remicade Gains Pediatric Crohn’s Disease Indication
Remicade is the first Crohn's disease therapy approved for pediatric patients following its May 19 supplemental BLA approval
Abbott's Humira Approved For Psoriatic Arthritis, First-Line Rheumatoid Arthritis
Abbott will support dedicated sales representatives to detail Humira to dermatologists following psoriatic arthritis approval.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.